- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 237/10 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
Patent holdings for IPC class C07C 237/10
Total number of patents in this class: 128
10-year publication summary
|
15
|
8
|
5
|
12
|
8
|
6
|
14
|
8
|
11
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ecolab USA Inc. | 5753 |
9 |
| Molecular Transfer, Inc. | 25 |
8 |
| Championx LLC | 621 |
5 |
| Halliburton Energy Services, Inc. | 21257 |
3 |
| Merck Patent GmbH | 5669 |
3 |
| The Governing Council of The University of Toronto, | 1541 |
3 |
| Mitsubishi Tanabe Pharma Corporation | 424 |
3 |
| Ustav Organicke Chemie a Biochemie AV CR, V.v.i. | 127 |
3 |
| The Procter & Gamble Company | 21919 |
2 |
| Acuitas Therapeutics Inc. | 133 |
2 |
| Centre hospitalier Regional et universitaire de Lille (chru) | 33 |
2 |
| CTI Bio | 2 |
2 |
| CUBE BIOTECH GmbH | 46 |
2 |
| Quadriga Biosciences, Inc. | 22 |
2 |
| Samyang Holdings Corporation | 212 |
2 |
| Teijin Pharma Limited | 258 |
2 |
| Universidad de Castilla-la Mancha | 82 |
2 |
| Cytiva BioProcess R&D AB | 319 |
2 |
| Shenzhen Shenxin Biotechnology Co., Ltd. | 41 |
2 |
| Novartis AG | 10338 |
1 |
| Other owners | 68 |